Skip to content

TAP Block: Does Volume Make a Difference?

Lumbar Transversus Abdominal Plane (TAP) Block: Does Volume Make a Difference?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01307215
Enrollment
31
Registered
2011-03-02
Start date
2011-04-01
Completion date
2013-03-01
Last updated
2026-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative Pain

Keywords

TAP block, incision pain, total hysterectomy

Brief summary

Patients who have abdominal surgery will experience pain from the incision. The lumbar TAP block is a procedure used to reach the nerve endings in the abdominal wall so that there is a reduction in pain after surgery. Using ultrasound guidance, a solution of ropivacaine will be injected after surgery. The aim of this study is to determine the effect of changes in the volume of the injection.

Detailed description

Pain from a surgical incision happens in most patients. During the perioperative period, the use of the TAP block has been shown to reduce pain scores, opioid consumption and sedation scores. Also, there is a trend towards a reduction of post-operative nausea and vomiting. The aim of the block is to reach the distal nerve endings of the abdominal wall from T6 to L1 dermatomes using ultrasound guidance with a single shot of ropivacaine at different volumes. Currently, there is consensus about optimal procedure-specific volumes and local anesthetic concentrations for lumbar TAP blocks. This is a pilot study and the purpose being is it feasible to do a large scale clinical study to determine the influence of increasing the local anesthetic volume.

Interventions

DRUGRopivacaine

20mLs of 0.5%

Sponsors

McMaster University
Lead SponsorOTHER
St. Joseph's Healthcare Hamilton
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 18-70 years old * total abdominal hysterectomy * capable of completing informed consent * no previous chronic opioid use * no previous abdominal wall surgeries

Exclusion criteria

* patient refusal * contraindication to regional anesthesia: coagulopathy, anticoagulant use, bleeding disorders, * local or systemic infection * local anesthetic allergy * BMI\>35

Design outcomes

Primary

MeasureTime frameDescription
To assess the feasibility of a large scale clinical study to determine the influence on increasing the local anesthetic volume.6 monthThis will be shown as a number and a percenttage of patients recruited and randomized.

Secondary

MeasureTime frameDescription
Using ice and pinprick, determine the dermatomal block distribution at 2,6,12,24 and 48 hours post block.48 hoursThe assessor will measure the extend of the block distribution at the various time intervals.
Pain scores at 2,6,12,24, and 48 hours post-block.48 hoursUsing a visual analog scale, patient pain scores will be assessed.
Patient-controlled analgesia opioid requirements at 2,6,12,24 and 48 post-block.48 hoursRecord drug consumption at the time intervals
Incidence of post-operative nausea and vomiting at 2,6,12,24, and 48 hours.48 hours
Block failure rate.48 hoursBlock failure rate is defined as the lack of any sensory block following the TAP block.
Patient's overall satisfaction.48 hoursUsing a LIKERT score, patient satisfaction will be measured.
Discharge time from PACU.24 hoursThe time in which the patient is discharged from the recovery room.

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORMauricio Forero, MD

McMaster University/St. Joseph's Healthcare

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 11, 2026